View in EDS

Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid chronic rhinosinusitis with nasal polyps (CRSwNP).

Saved in:
Bibliographic Details
Title: Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid chronic rhinosinusitis with nasal polyps (CRSwNP).
Authors: Lugogo NL; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan., Han JK; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia., Peters AT; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Lee SE; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Kraft M; Department of Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, New York., Margolis MK; Patient Centered Science, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Shenoy SF; Global Medical Affairs, Amgen, Thousand Oaks, California., Martin N; Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts; Cytel Inc, Waltham, Massachusetts., Chandarana S; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland. Electronic address: chris.ambrose@astrazeneca.com.
Source: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2026 May; Vol. 136 (5), pp. 531-537.e6. Date of Electronic Publication: 2026 Feb 13.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41692339
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid chronic rhinosinusitis with nasal polyps (CRSwNP).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lugogo+NL%22">Lugogo NL</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Han+JK%22">Han JK</searchLink>; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia.<br /><searchLink fieldCode="AU" term="%22Peters+AT%22">Peters AT</searchLink>; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Lee+SE%22">Lee SE</searchLink>; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kraft+M%22">Kraft M</searchLink>; Department of Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, New York.<br /><searchLink fieldCode="AU" term="%22Margolis+MK%22">Margolis MK</searchLink>; Patient Centered Science, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Shenoy+SF%22">Shenoy SF</searchLink>; Global Medical Affairs, Amgen, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Martin+N%22">Martin N</searchLink>; Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts; Cytel Inc, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Chandarana+S%22">Chandarana S</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland. Electronic address: chris.ambrose@astrazeneca.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229503580%22">Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology</searchLink> [Ann Allergy Asthma Immunol] 2026 May; Vol. 136 (5), pp. 531-537.e6. <i>Date of Electronic Publication: </i>2026 Feb 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+College+of+Allergy%2C+Asthma%2C+and+Immunology%22">American College of Allergy, Asthma, and Immunology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9503580 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-4436 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210811206%22">10811206 </searchLink><i>NLM ISO Abbreviation: </i>Ann Allergy Asthma Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41692339
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.anai.2026.02.002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 531
    Titles:
      – TitleFull: Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid chronic rhinosinusitis with nasal polyps (CRSwNP).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lugogo NL
      – PersonEntity:
          Name:
            NameFull: Han JK
      – PersonEntity:
          Name:
            NameFull: Peters AT
      – PersonEntity:
          Name:
            NameFull: Lee SE
      – PersonEntity:
          Name:
            NameFull: Kraft M
      – PersonEntity:
          Name:
            NameFull: Margolis MK
      – PersonEntity:
          Name:
            NameFull: Shenoy SF
      – PersonEntity:
          Name:
            NameFull: Martin N
      – PersonEntity:
          Name:
            NameFull: Chandarana S
      – PersonEntity:
          Name:
            NameFull: Ambrose CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1534-4436
          Numbering:
            – Type: volume
              Value: 136
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
              Type: main
ResultId 1